| TRVN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the TRVN market cap history going back to 3/17/2014:
Also see: TRVN Shares Outstanding History and TRVN YTD Return |
TRVN Market Cap History — Trevena Capitalization Over Time
As of 8/6/2024 Trevena has a market cap of 4.22 million. Investors often follow the TRVN market cap history to compare the size of the company over time.
This page shows TRVN market capitalization trends over time, with 41 market cap datapoints presented, dating back to 3/17/2014.
| TRVN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TRVN Historical Market Cap: -31.67% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TRVN Stock Price Chart |
| About Trevena Inc |
| Trevena is a biopharmaceutical company. Co.'s primary product, OLINVYK™ (oliceridine) injection, is an opioid agonist for use in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. Co.'s product candidates include: TRV250, which is a G-protein biased delta-opioid receptor agonist as a compound with a mechanism for the treatment of acute migraine; TRV045, which is Co.'s sphingosine-1-phosphate receptor modulator that may provide a non-opioid approach to managing chronic pain; as well as TRV734, a new chemical entity targeting the same mechanism of action at the mu opioid receptor as OLINVYK. We show 41 historical shares outstanding datapoints in our TRVN shares outstanding history coverage, used to compute TRVN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TRVN market cap history over the course of time is important for investors interested in comparing TRVN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TRVN versus a peer is one thing; comparing TRVN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TRVN can fluctuate over the course of history. With this page we aim to empower investors researching TRVN by allowing them to research the TRVN market cap history. |
| TRVN Current Stock Quote |
Quotes delayed 20 minutes  Free TRVN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| TRVN Share Performance |
| Market Cap Peers |
| Trevena (TRVN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
TSBX Market Cap History TSHA Market Cap History TSRO Market Cap History TSVT Market Cap History TTNP Market Cap History TTOO Market Cap History TTPH Market Cap History TVRD Market Cap History TVTX Market Cap History TVTY Market Cap History More Healthcare companies » |
TRVN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
